Compare Quest Diagnostics Inc (DGX) vs Plug Power Inc (PLUG) Price & Performance

Quest Diagnostics (DGX) trades at $227.00, down 0.64% on the day, with the stock showing strong fundamental performance including three consecutive quarterly earnings beats and revenue growth from $9.9B in 2024 to $11.04B in 2025. Technical indicators signal bearish momentum with the current price near key support at $226, while the company maintains solid profitability with 9.19% net income margin and 14.35% ROE. Recent developments include positive clinical study results and a new partnership with Apple Health app for lab testing integration.

The investment outlook remains positive with analyst consensus target of $250 representing 10% upside potential, though Medicare reimbursement cuts pose near-term headwinds. Growth drivers include advanced diagnostics expansion and consumer testing demand, balanced against technical weakness and regulatory uncertainty. The stock offers value with reasonable P/E of 24.1 and consistent dividend payments.

Plug Power (PLUG) trades at $1.78, down 4.3% today, reflecting ongoing operational challenges despite recent strategic partnerships. The stock shows bearish technical signals with negative moving averages, while fundamentally the company continues to report significant losses with a -220.59% net income margin and negative cash flow. Recent news highlights a major 280 MW electrolyzer agreement with Arcadia eFuels and expansion in Australia/New Zealand, providing potential growth catalysts amid persistent financial headwinds.

The outlook remains challenging with substantial execution risks, though analyst consensus suggests 75% upside to the $3.13 price target. Key risks include continued cash burn, high debt levels, and competitive pressure in the hydrogen sector. Investment appeal depends on successful commercialization of green hydrogen projects and path to profitability.